Earnings Call
Apr 30, 2026
Q1 FY2026
EPS Estimate
0.47
EPS Actual
0.56
Post-Earnings Close
$61.35
Earnings Reaction
+3.0%
DexCom opened 2026 with its strongest margin performance in years, pairing 15% reported revenue growth with a gross margin of 63.5%, up 600 basis points year-over-year and flat sequentially despite typical Q1 seasonality headwinds. Non-GAAP EPS of $0.56 beat the $0.47 consensus estimate by a wide margin, and adjusted EBITDA reached 36% of revenue, a level that would have seemed aspirational just a year ago when the same metric stood at 22.2%. Free cash flow was strong enough to push the cash balance above $2.4 billion, up more than $400 million from year-end 2025. Management raised full-year operating margin and EBITDA margin guidance while holding gross margin guidance steady, a deliberate choice to absorb 50-100 basis points of potential risk from oil-linked resin and freight costs in the current geopolitical environment.
Report generated on May 2, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full DXCM analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.